Interestingly, overexpression of these miRNAs is correlated with reduction in CCND3 suggesting that BCR-ABL induced oncogenic miRNAs are involved in the downregulation of CCND3 in CML [161]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.